Literature DB >> 6668486

Hairy cell leukemia: lessons learned in twenty-five years.

H M Golomb.   

Abstract

This review was written to highlight the lessons learned in HCL in the past 25 years. It should serve as a guideline to practicing hematologists and oncologists regarding the diagnosis and management of HCL patients. It should stimulate investigators in training to realize that a disease can be understood with time; however, additional clinical observations and laboratory experiments may help to improve the survival rate even more.

Entities:  

Mesh:

Year:  1983        PMID: 6668486     DOI: 10.1200/JCO.1983.1.10.652

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  5 in total

1.  Case report 410: Hairy cell leukemia infiltrating the femora.

Authors:  C Peterson; P A Kaplan; K M Lorenzen
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

2.  [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].

Authors:  N Niederle; C Doberauer; O Kloke; K Höffken; C G Schmidt
Journal:  Klin Wochenschr       Date:  1987-07-15

3.  Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Authors:  Michael R Grever; Omar Abdel-Wahab; Leslie A Andritsos; Versha Banerji; Jacqueline Barrientos; James S Blachly; Timothy G Call; Daniel Catovsky; Claire Dearden; Judit Demeter; Monica Else; Francesco Forconi; Alessandro Gozzetti; Anthony D Ho; James B Johnston; Jeffrey Jones; Gunnar Juliusson; Eric Kraut; Robert J Kreitman; Loree Larratt; Francesco Lauria; Gerard Lozanski; Emili Montserrat; Sameer A Parikh; Jae H Park; Aaron Polliack; Graeme R Quest; Kanti R Rai; Farhad Ravandi; Tadeusz Robak; Alan Saven; John F Seymour; Tamar Tadmor; Martin S Tallman; Constantine Tam; Enrico Tiacci; Xavier Troussard; Clive S Zent; Thorsten Zenz; Pier Luigi Zinzani; Brunangelo Falini
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

Review 4.  Moxetumomab Pasudotox: Clinical Experience in Relapsed/Refractory Hairy Cell Leukemia.

Authors:  Julie Feurtado; Robert J Kreitman
Journal:  Clin J Oncol Nurs       Date:  2019-06-01       Impact factor: 1.027

Review 5.  How I treat hairy cell leukemia.

Authors:  Michael R Grever
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.